Summary of Research
Before developing the Excel V KTP and Nd:YAG laser, Cutera asked physicians what they would want in their ideal vascular laser system. Feedback we heard included the versatility in parameters to treat all lesions with a high safety margin, efficient cooling with excellent visibility, an easy-to-use interface, no consumables and a modern design that runs efficiently. We also heard the proof of the system would be the ability to create purpura in a port wine stain, since a system that delivered these parameters could be adjusted to a range of other treatments.
The Excel V laser is designed from the ground up to meet these criteria. The design features a new high-power laser that allows operation at both the 532 and 1064 nm wavelengths, advanced hardware and software to run the system, and an entirely new interface to simplify parameter selection.
Cutera is committed to ongoing research and has engaged some of the leading experts on cosmetic vascular conditions to study the efficacy and safety of the Excel V in treating a variety of indications.
Current IRB Studies in Progress with the following Experts:
Port Wine Stains – Roy Geronemus, MD – Dermatologist, New York, NY
Laser & Skin Surgery Center of NY
Dr. Geronemus is a world renowned laser expert with particular expertise in vascular treatments. He has treated thousands of port wine stain patients and is currently doing a clinical study on PWS with the Excel V
Leg Veins – Eric Bernstein, MD – Dermatologist, Philadelphia, PA
Main Line Center for Laser Surgery
Dr. Bernstein has extensive experience with the VBeam and the Coherent VersaPulse. He has authored several papers on treating leg veins and is currently doing a clinical study using the Excel V for unwanted cosmetic leg veins.
Poikiloderma – Brian Zelickson, MD – Dermatologist, Minneapolis, MN
Zel Skin & Laser Specialists
Dr. Zelickson is a well-respected dermatologist, dermapathologist, and a leading cosmetic laser expert, who has authored many clinical studies. Dr. Zelickson is the current President of ASLMS. His clinical study using the Excel V for poikiloderma– a condition that has been difficult to treat with the VBeam – is now underway.